Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
ISPE Releases Survey Report, "Enabling Global Pharmaceutical Innovation: Delivering for Patients" | ||
By: PR Newswire Association LLC. - 23 Apr 2024 | Back to overview list |
|
Nearly 400 pharmaceutical professionals weigh in on challenges and opportunities with introducing technological innovation, citing economic factors and regulatory concerns as key barriers. NORTH BETHESDA, Md., April 23, 2024 /PRNewswire-PRWeb/ -- The International Society for Pharmaceutical Engineering (ISPE) has released a report on its survey to uncover and address the barriers to pharmaceutical innovation, entitled "Enabling Global Pharmaceutical Innovation: Delivering for Patients." The report includes insights from 391 respondents from the pharmaceutical industry with a diverse mix of large to small manufacturers, contract and development organizations, suppliers, facilities and software service providers, and more, from multiple countries and reflecting multiple product modalities. The majority of responses came from innovative (brand name) companies. "The pharmaceutical industry is committed to developing innovative technology and continually improving," said Roger Nosal, Head of Global Regulatory Strategy and Submissions, NGT Biopharma, and chair of the initiative. "These survey findings identify sources of the key barriers that limit progress toward technological innovation and opportunities for improvement that increase quality assurance for patients." Key challenges and determining factors impacting innovation are as follows:
Key recommendations for regulators and the industry are as follows:
"The regulatory environment is complex. As this report indicates, regulatory harmonization will be a critical component to enabling innovation in the pharmaceutical industry," said Thomas Hartman, President and CEO of ISPE. "ISPE strives to facilitate industry-wide clarity surrounding regulations. Survey reports like this one, which provide statistically significant data points drawing from insights shared by hundreds of professionals, will enable us to advance efforts between the industry and regulators and ultimately help to shape the future of the pharmaceutical industry." As a next step, ISPE's Enabling Global Pharmaceutical Innovation Initiative team will present proposals to multiple regulatory agencies intended to promote practical incentives for the industry and regulatory authorities to address specific challenges to innovation and continual improvement initiatives. Additionally, the ISPE team will work with industry and equipment suppliers to understand the steps needed to introduce innovative technologies and develop a "points to consider document" with key considerations about how to address specific challenges to innovation and continual process improvement. For more information and to view the full report, visit https://ispe.org/initiatives/regulatory/enabling-global-pharmaceutical-innovation-delivering-patients. About ISPE Media Contact Katie LeChase, ISPE, +1-360-718-9771, KLeChase@ISPE.org, https://ispe.org/ View original content:https://www.prweb.com/releases/ispe-releases-survey-report-enabling-global-pharmaceutical-innovation-delivering-for-patients-302124366.html SOURCE ISPE |
||
|
||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |